Work

TAX-TORC: An investigator initiated phase I study combining the dual mTORC1/2 inhibitor AZD2014 in combination with weekly paclitaxel in high-grade serous ovarian cancer

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw368.05

Authors: U. Banerji, B. Basu, J.F. Spicer, R. Wilson, E. Hall, R. Sundar, S. Kumar, Y. Wu, V. Coyle, S. Carreira, M. Parmar, J.C. Dawes, S. Banerjee, J.S. de Bono

Institutions: Institute of Cancer Research, Addenbrooke's Hospital, Guy's Hospital, King's College London, Queen's University Belfast

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2586935260

FWCI:

Cites:

Cited by:

Related to: 10